MedPath

TARO-ADAPALENE/BENZOYL PEROXIDE

TARO-ADAPALENE/BENZOYL PEROXIDE

Approved
DIN Number

02456923

Drug Class

Human

Market Date

Oct 1, 2019

Company
HC

Taro Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02456923
AIG Number0252888001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D10AD53 ADAPALENE, COMBINATIONS
Product Specifications
Dosage FormGel
Route of AdministrationTopical
AHFS Classification84:28.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

ADAPALENEActive
Strength: 0.1 % / W/W
Monograph: ADAPALENE
BENZOYL PEROXIDEActive
Strength: 2.5 % / W/W
Monograph: BENZOYL PEROXIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.